|
|
||||||||
Review |
1 Alfa Institute of Biomedical Sciences (AIBS), 9 Neapoleos Street, 151 23 Marousi, Athens, Greece
2 Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts, USA
Correspondence
Matthew E. Falagas
matthew.falagas{at}tufts.edu
This article has been cited by other articles:
![]() |
T. Kelesidis, D. E. Karageorgopoulos, I. Kelesidis, and M. E. Falagas Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies J. Antimicrob. Chemother., November 1, 2008; 62(5): 895 - 904. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Giske, D. L. Monnet, O. Cars, Y. Carmeli, and on behalf of ReAct-Action on Antibiotic Resistance Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli Antimicrob. Agents Chemother., March 1, 2008; 52(3): 813 - 821. [Full Text] [PDF] |
||||
![]() |
G. A. Pankuch, G. Lin, H. Seifert, and P. C. Appelbaum Activity of Meropenem with and without Ciprofloxacin and Colistin against Pseudomonas aeruginosa and Acinetobacter baumannii Antimicrob. Agents Chemother., January 1, 2008; 52(1): 333 - 336. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. W. Govan Multidrug-resistant pulmonary infection in cystic fibrosis - what does 'resistant' mean? J. Med. Microbiol., December 1, 2006; 55(Pt 12): 1615 - 1617. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |